Rebecca Liang

Stock Analyst at Bernstein

(4.20)
# 1,301
Out of 4,491 analysts
77
Total ratings
55.6%
Success rate
23.2%
Average return

Stocks Rated by Rebecca Liang

Akeso, Inc.
May 31, 2026
Rated: Hold
Price Target: $130.00
Current: $96.50
Upside: +34.72%
Hansoh Pharmaceutical Group Company Limited
Apr 22, 2026
Maintained: Buy
Price Target: $44.00$47.00
Current: $31.56
Upside: +48.92%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Mar 26, 2026
Maintained: Buy
Price Target: $545.00$526.00
Current: $470.60
Upside: +11.77%
BeOne Medicines AG
Mar 18, 2026
Maintained: Buy
Price Target: $412
Current: $299.68
Upside: +37.48%
Innovent Biologics, Inc.
Mar 12, 2026
Maintained: Buy
Price Target: $115.00
Current: $86.60
Upside: +32.79%
Sino Biopharmaceutical Limited
Feb 9, 2026
Maintained: Hold
Price Target: $7.90
Current: $5.00
Upside: +58.00%
CSPC Pharmaceutical Group Limited
Feb 9, 2026
Maintained: Hold
Price Target: $10.70
Current: $7.79
Upside: +37.36%
Zai Lab Limited
Feb 9, 2026
Maintained: Hold
Price Target: $18.00
Current: $15.02
Upside: +19.84%